Navigation Links
CulGenex™ by Hardy Diagnostics Assists Medical Researchers!
Date:9/16/2010

SANTA MARIA, Calif., Sept. 16 /PRNewswire/ -- Hardy Diagnostics, an FDA licensed and ISO certified biomedical firm, is pleased to announce the release of CulGenex™, a new brand of culture media, biological buffers, molecular grade waters, electrophoresis gels, nucleic acid purification kits, and transfection reagents for molecular biology researchers. Developed under the leadership of Dr. Chris Crowe (molecular biologist from the University of Pittsburgh) and Dr. John Powers (formerly of the NIH), CulGenex™ offers a wide selection of high quality molecular biology products, suitable for use in a wide range of molecular biology laboratories, including, medical and pharmaceutical research and agricultural science. The CulGenex™ product line will provide scientists with all the materials that they need to isolate, purify, and work with DNA and proteins. Over 200 molecular biology products are in the CulGenex product offering, which are manufactured in our state-of-the-art ISO certified manufacturing facility in Santa Maria, CA.  

(Photo:  http://photos.prnewswire.com/prnh/20100916/LA66359)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100916/LA66359)

ABOUT HARDY DIAGNOSTICSHardy Diagnostics is an FDA licensed and ISO 13485 certified manufacturer of medical devices for microbiological procedures in both clinical and industrial laboratories. The company manufactures over 3,000 products for the culture and identification of bacteria and fungi from its Santa Maria, California headquarters. Currently over 6,000 laboratories are serviced by Hardy Diagnostics throughout the nation.

The company was founded in 1980 by Jay Hardy, a Clinical Laboratory Scientist from Santa Barbara, CA. Today, Hardy Diagnostics maintains seven distribution centers throughout the U.S. and exports products to over 30 foreign distributors.

The company's mission is to partner with its laboratory customers to prevent and diagnose disease. For more information on CulGenex, visit http://www.hardydiagnostics.com/culgenex.html.Contact Information:Contact Person: Christopher CataniCompany Name: HARDY DIAGNOSTICSAddress: 1430 West McCoy Lane, Santa Maria, CA 93455Phone Number: (805) 346-2766, Ext: 5696Fax Number: (805) 346-2760Email Address: CataniC@HardyDiagnostics.comCulGenex Website: http://www.hardydiagnostics.com/culgenex.html
'/>"/>

SOURCE Hardy Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hardy Diagnostics Named in Inc. 5000
2. U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index™
3. Roche Diagnostics Introduces Full Line of 9-Minute STAT Assays for Cardiac Biomarker Testing on cobas 6000 Analyzer Series
4. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
5. Quest Diagnostics Care360™ EHR Module Receives Preliminary ARRA IFR Stage 1 Certification
6. Abviva Announces Notice of Canadian Patent for Technology Used in Breast Cancer Diagnostics and Therapeutics
7. MedPro Imaging to Supply Mobile Ultrasound Diagnostics to Chicago Bears Players
8. Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
9. Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
10. DeviceSpace Showcases Medical Device and Diagnostics Companies
11. Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):